3-O-beta-D-Galactopyranosylproanthocyanidin A5\'



Compound IDCDAMM01527
Common name3-O-beta-D-Galactopyranosylproanthocyanidin A5\'
IUPAC name5,13-bis(3,4-dihydroxyphenyl)-21-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19-tetrol
Molecular formulaC36H34O17

Experimental data

Retention time2.7
Adduct[M+H]+
Actual mz739.188
Theoretical mz739.187
Error1.11
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.7445

Identifiers and class information

Inchi keyJUIIUJBWZYKSEP-UHFFFAOYNA-N
SmilesOC=1C=C(O)C2=C(OC3(OC4=CC(O)=C5C(OC(C6=CC=C(O)C(O)=C6)C(O)C5)=C4C2C3OC7OC(CO)C(O)C(O)C7O)C8=CC=C(O)C(O)=C8)C1
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)738.654
Computed dipole moment(dipole)6.757
Total solvent accessible surface area (SASA)881.243
Hydrophobic component of SASA (FOSA)149.029
Hydrophilic component of SASA (FISA)444.192
Pie component of the SASA (PISA)288.021
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1803.67
Number of hydrogen bond donors (donorHB)12
Number of hydrogen bond acceptors (accptHB)19.4
Free energy of solvation of dipole (dip^2/V)0.0253137
Index of cohesive interaction in solids (ACxDN^.5/SA)0.07626
Globularity descriptor (glob)0.813156
Predicted polarizability in cubic angstroms (QPpolrz)59.148
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.586
Predicted octanol/gas partition coefficient (QPlogPoct)49.651
Predicted water/gas partition coefficient (QPlogPw)40.196
Predicted octanol/water partition coefficient (QPlogPo/w)-1.338
Predicted aqueous solubility (QPlogS)-3.121
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.146
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.929
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.608
Predicted brain/blood partition coefficient (QPlogBB)-4.819
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.165
Predicted skin permeability, log Kp (QPlogKp)-7.251
PM3 calculated ionization potential (IP(ev))8.907
PM3 calculated electron affinity (EA(eV))0.052
Number of likely metabolic reactions (#metab)15
Prediction of binding to human serum albumin (QPlogKhsa)-0.882
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)278.042
Number of nitrogen and oxygen atoms (#NandO)17
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P60568IL2Interleukin-2T61698SEA
P49763PGFPlacenta growth factorT70792SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD

Copyright © 2025